News

TTP488 prevents interaction of a material found in the Alzheimer’s patients cells, referred to as amyloid beta (Aß). The candidate is the first drug related to Receptor for

According to the agreement, Bayer will apply Chromobody technology for real time monitoring of cell cycle progression in drug discovery. The Chromobody Technology, a patented, universal live cell

The Lipo 7 consists of vitamins B6 & B12 (methylcobalamin), methionine, inositol, choline (MIC), leucine and chromium that help in metabolizing and burning fats in the body. The

Patients were enrolled at 18 cancer institutions across the US for the study. The Phase II trial will evaluate the efficacy of TSC, when added to existing GBM

The company is looking for 1kg of Adva-27a for the forthcoming IND-Enabling animal toxicity studies and Phase I clinical trials. Once the animal toxicity studies are completed, an

The technology was developed at the University of Bristol by professor Varinder Aggarwal and colleagues. It is said to simplify the synthesis of prostaglandins, improve manufacturing efficiency by

The new antibodies will target phosphorylated Histone H2A.X and p53 validated, for immunohistochemistry using both whole-mount and paraffin-embedded zebrafish embryos as well as western blotting and immunohistochemistry using

A total of 236 patients with moderate-to-severe DES will be randomized in the double-masked study to receive two oral doses of CF101 and a placebo for a 24-week

According to the deal, Hyglos will leverage Lonza’s patent-protected recombinant factor C technology in the production of endotoxin products. As part of the settlement, Lonza will cancel a